A review published in the December 9, 2008 issue of the Journal of the American College of Cardiology describes the involvement of deficient vitamin D levels in common risk factors for cardiovascular disease (including high blood pressure, diabetes, and obesity) and in cardiovascular events.
Vitamin D deficiency is estimated to affect up to half of all adults and 30 percent of children in the United States. While the vitamin’s role in bone health has long been known, a flurry of recent studies have uncovered associations between deficient levels of the vitamin and a number of diseases, including cardiovascular disease. In their review, Michael F. Holick, MD, PhD and colleagues note that insufficient levels of vitamin D activate the renin-angiotensin-aldosterone system, which can lead to hypertension and thickening of the heart and blood vessel walls. Altered hormone levels related to a deficiency of vitamin D (which is also a hormone) increase the risk of diabetes, which is a well known risk factor for the development of cardiovascular disease. In 15,088 subjects from the NHANES III national cohort registry, higher vitamin D levels were related to a lower risk of diabetes as well as hypertension, high triglycerides, and obesity. And among Framingham Heart Study participants who had levels of vitamin D of less than 15 nanograms per milliliter upon enrollment, the risk of subsequent cardiovascular events was twice as great as the risk experienced by those with higher levels of the vitamin.
Chronic vitamin D deficiency is associated with secondary hyperparathyroidism, which increases the risk of inflammation and cardiovascular events. Elevated parathyroid levels were associated with an increased risk of death among older individuals compared to those with normal levels over the course of follow-up in a recent observational study.
"We are outside less than we used to be, and older adults and people who are overweight or obese are less efficient at making vitamin D in response to sunlight," stated review coauthor James H. O'Keefe, MD, who is a cardiologist and director of Preventive Cardiology at the Mid America Heart Institute in Kansas City, Missouri. The authors’ strategy for restoring vitamin D to optimal levels in cardiovascular disease patients includes initial treatment with 50,000 international units (IU) vitamin D2 or D3 weekly for 8 to 12 weeks followed by maintenance with 1,000 to 2,000 IU daily. They also suggest limited sun exposure as a means of increasing vitamin D. They observe that supplementation with vitamin D is safe and that such effects as elevated calcium levels and kidney stone development have only rarely been observed among individuals who consume 20,000 IU per day or more.
"Vitamin D deficiency is an unrecognized, emerging cardiovascular risk factor, which should be screened for and treated," stated Dr O'Keefe. "Vitamin D is easy to assess, and supplementation is simple, safe and inexpensive."
"Restoring vitamin D levels to normal is important in maintaining good musculoskeletal health, and it may also improve heart health and prognosis," Dr. O'Keefe concluded. "We need large randomized controlled trials to determine whether or not vitamin D supplementation can actually reduce future heart disease and deaths."
Interestingly, only about half the people with coronary artery disease have traditional risk factors, such as elevated cholesterol, smoking, high blood pressure, and obesity. Yet all patients with atherosclerosis suffer from endothelial dysfunction and the damaging effects of oxidized LDL, which provides an important building block for plaque deposits. Antioxidant therapy is therefore important to limit the oxidization of LDL and improve the health of the endothelium by limiting the damage caused by inflammatory cytokines. The following antioxidants are some of the most effective studied in atherosclerosis:
Lipoic acid. This naturally occurring antioxidant serves as a coenzyme in energy metabolism of fats, carbohydrates, and proteins. It can regenerate thioredoxin, vitamin C, and glutathione, which in turn can recycle vitamin E. Lipoic acid also helps manage proper serum glucose levels in diabetic patients (Packer L et al 2001). In animal studies, it has been shown to reduce endothelial dysfunction (Lee WJ et al 2005a). Human studies have found that lipoic acid improves endothelial function among people with metabolic syndrome (Sola S et al 2005). Lipoic acid works best in combination with antioxidants including vitamin E, coenzyme Q10, carnitine, and selenomethionine (Mosca L et al 2002).
Garlic. Aged garlic extract has been studied for its ability to reduce inflammation and the damaging effects of cholesterol in the endothelium (Orekhov AN et al 1995). In one study of 15 men with coronary artery disease who were also being treated with statin drugs and low-dose aspirin, two weeks of supplementation with aged garlic extract significantly improved blood flow by improving endothelial function (Williams MJ et al 2005).
To measure the antioxidant strengths of food and other substances, scientists use what is called the ORAC score. A higher score means the food is better at protecting the body's cells from free radical-induced damage. So, the higher a food's ORAC score, as in dark-skinned fruits and vegetables, the better it is for you. However, problems with availability, the perishable nature, and the cost of obtaining a wide variety of high-ORAC fruits and vegetables on a daily basis mean they are often difficult to get in the typical American diet.
To overcome these issues, Life Extension offers Berry Complete formula, which provides a concentrated blend of fruit and vegetable extracts that have some of the highest ORAC scores around. Each capsule is packed with scientifically proven polyphenols and anthocyanins from seasonal and perishable fruits and legumes that are typically the highest in ORAC values. Just one capsule provides the antioxidant capacity of more than 50% of the daily recommended five a day intake of fruits and vegetables.
New studies have tied inflammation to overexpression of a protein molecule called nuclear factor-kappa B (NF-kappaB). NF-kappaB acts like a switch to turn on genes that produce the body’s inflammatory responses. Because NF-kappaB‘s expression increases in aging adults, scientists have sought ways to modulate NF-kappaB and its effects in the body.
Curcumin has been shown to exert powerful inhibitory effects on NF-kappaB activation within the body. Curcumin inhibits overexpression of NF-kappaB.
Super Bio-Curcumin® contains a patent-pending synergistic blend of curcuminoids and sesquiterpenoids with enhanced bioavailability and sustained retention time in the body confirmed by human clinical studies. Super Bio-Curcumin® is a “next generation” in delivery of curcumin compounds that no longer requires high doses of curcumin to reach sustainable levels of curcumin in the blood plasma.